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Abstract
A deficient retinoic acid signaling has been suggested to be an important cause of the clinical
inefficacy of all-trans retinoic acid (ATRA) therapy in nonpromyelocytic (non-PML) forms of acute
myeloid leukemia (AML). The general aim of the present work was to explore novel ways to take
advantage of the anti-leukemic potential of ATRA, and, specifically, to search for a synergism
between ATRA and epigenetic drugs. Because previous reports have found no major influence of
ATRA on DNA methylation, we investigated whether ATRA-mediated differentiation of the U937
and HL-60 AML cell lines, both lacking a PML-retinoic acid receptor (RAR) fusion product, is
accompanied by early-appearing and weak changes in CpG methylation. We report that in HL-60
cells, by using a highly quantitative analysis of a set of genes found to be abnormally expressed
in AML, polymerase chain reaction (PCR)-amplified p16 gene promoter molecules (each with 15
CpG sites), exhibited a CpG methylation level of 0-4% in untreated cells, which increased to 4-
21% after treatment with ATRA for seven days. In contrast to HL-60 cells, U937 cells exhibited a
very high CpG methylation level in p16, and ATRA did not influence the promoter methylation of
this  gene.  In  the total  CCGG sites  of  the genome,  analysed using a methylation-sensitive
restriction enzyme, CpG methylation was significantly lower in ATRA-treated HL-60 (p<0.01) and
U937 cells (p<0.05) than in controls. Taken together, our findings show that ATRA can influence
DNA methylation,  and suggest  that  future  research  should  investigate  whether  epigenetic
modulation may evoke a clinical effect of ATRA in leukemia.
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